Abstract
The article has been withdrawn at the request of the author of the journal Current Pharmaceutical Design CPD:
Bentham Science apologizes to the readers of the journal for any inconvenience this may cause.
Bentham Science Disclaimer:
It is a condition of publication that manuscripts submitted to this journal have not been published and will not be
simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been
published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is
strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal
right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting
a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article
is accepted for publication.
Current Pharmaceutical Design
Title:Withdrawal Notice: Targeting lncRNAs for Cardiovascular Therapeutics in Coronary Artery Disease
Volume: 24
Author(s): Dongsheng Yu, Chuanfeng Tang, Peiyu Liu, Weichun Qian* Liang Sheng
Affiliation:
- Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, Nanjing,China
Abstract: The article has been withdrawn at the request of the author of the journal Current Pharmaceutical Design CPD:
Bentham Science apologizes to the readers of the journal for any inconvenience this may cause.
Bentham Science Disclaimer:
It is a condition of publication that manuscripts submitted to this journal have not been published and will not be
simultaneously submitted or published elsewhere. Furthermore, any data, illustration, structure or table that has been
published elsewhere must be reported, and copyright permission for reproduction must be obtained. Plagiarism is
strictly forbidden, and by submitting the article for publication the authors agree that the publishers have the legal
right to take appropriate action against the authors, if plagiarism or fabricated information is discovered. By submitting
a manuscript, the authors agree that the copyright of their article is transferred to the publishers if and when the article
is accepted for publication.
Export Options
About this article
Cite this article as:
Yu Dongsheng, Tang Chuanfeng, Liu Peiyu, Qian Weichun*, Sheng Liang, Withdrawal Notice: Targeting lncRNAs for Cardiovascular Therapeutics in Coronary Artery Disease, Current Pharmaceutical Design 2018; 24 () . https://dx.doi.org/10.2174/1381612824666180108120727
DOI https://dx.doi.org/10.2174/1381612824666180108120727 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
In Vitro CYP2D Inhibitory Effect and Influence on Pharmacokinetics and Pharmacodynamic Parameters of Metoprolol Succinate by Terminalia arjuna in Rats
Drug Metabolism Letters Implications of Nanoscale Based Drug Delivery Systems in Delivery and Targeting Tubulin Binding Agent, Noscapine in Cancer Cells
Current Drug Metabolism Insulin-like Effects of Mt. Fuji Subsoil Water which Conta ins Vanadium on Cultured Cells: Insight from Japan
Current Traditional Medicine Systematic Review of Public Education and Policy for Stroke Prevention
Current Drug Targets Long-term Treatment of Venous Thromboembolism
Current Vascular Pharmacology The Resurgence of Aldosterone in Hypertension and Cardiovascular Disease
Current Hypertension Reviews Exploring Structure-based Drug Design for the Development of Multitarget Antihypertensives
Letters in Drug Design & Discovery Platelet and Soluble Glycoprotein VI - Novel Applications in Diagnosis and Therapy
Current Drug Targets Multifactorial Regulation of GPER Expression in Cancer Cells and Cardiomyocytes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Anemia in Chronic Heart Failure - Clinical and Prognostic Significance
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Editorial:Brain Hemorrhages and Future Management
Current Drug Targets Novel Strategies for the Detection of Systolic and Diastolic Heart Failure
Current Cardiology Reviews Three Musketeers for Lowering Cholesterol: Statins, Ezetimibe and Evolocumab
Current Medicinal Chemistry Multiple Targets for Drug-Induced Mitochondrial Toxicity
Current Medicinal Chemistry Rho-Kinase as a Drug Target for the Treatment of Airway Hyperresponsiveness in Asthma
Mini-Reviews in Medicinal Chemistry Resveratrol and Lifespan in Model Organisms
Current Medicinal Chemistry Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications
Current Medicinal Chemistry Micronutrients and Plant Food Bioactive Compounds Against Obesity Related Diseases
Endocrine, Metabolic & Immune Disorders - Drug Targets Total Bakkenolides Protects Neurons Against Cerebral Ischemic Injury Through Inhibition of Nuclear Factor-κB Activation
CNS & Neurological Disorders - Drug Targets Significance of Aspirin and Clopidogrel Resistance in Patients Undergoing Percutaneous Coronary Interventions
Current Vascular Pharmacology